Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy
Hyperammonaemic encephalopathy has been infrequently reported after both standard and high-dose chemotherapy for solid and haematological malignancies. It is important to consider this diagnosis for patients with unexplained behaviour changes or encephalopathy and this case report emphasizes this condition and the importance of early diagnosis and is the first reported in association with rituximab-containing chemotherapy.
Document Type: Research Article
Publication date: October 1, 2008